Developer docs
API playgroundTry for free, no card

Search company profiles

Elitech Group

Full company profile

uuid0007efo

Namestring
Elitech Group
Legal namestring
ELITechGroup SAS
Company typeenum
Private
Founded yearint
1992
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in vitro diagnostics, molecular diagnostics instruments, PCR testing systems, clinical laboratory reagents, biomedical analyzers
Industry5 codes
1Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
CodeHLAGAIAFPrimaryYes
2IVD Reagents, Assay Kits & Consumables (Non-instrument)
CodeHLAHAAAMPrimaryNo
3Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
CodeHLAAAMALPrimaryNo
4Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
CodeHLAGAIAIPrimaryNo
5Genomics & Molecular Diagnostics (Trial Support)
CodeHLAGAEADPrimaryNo
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
In-vitro Diagnostics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1In-vitro Diagnostic Products
TypeHardware Sales
Description

Development, manufacturing, and marketing of diagnostic products including instruments (InGenius, BeGenius sample-to-result systems), reagents (PCR assay kits), and software for molecular diagnostics, biomedical systems, and microbiology applications.

elitechgroup.com
2Diagnostic Reagents and Kits
TypeOne Time License
Description

CE-IVDR certified PCR assay kits including GI Bacterial PLUS ELITe MGB Kit, gastrointestinal panels, infectious disease assays for CMV, EBV, BK virus, HIV, HBV, HCV, and HHV-6, with nearly 60 CE-IVD parameters available.

elitechgroup.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Elitech Group develops, manufactures, and markets in-vitro diagnostic (IVD) products organized into three business areas: Molecular Diagnostics (PCR-based sample-to-result systems such as InGenius and BeGenius plus CE-IVD/IVDR assay kits), Biomedical Systems (automated slide stainers, osmometers, cytocentrifuges, ESR analyzers, chloridometers, digital cell analyzers), and Microbiology (human and veterinary diagnostic kits and sampling/transport products). It also sells proprietary MGB (Minor Groove Binder) probe chemistry and reagents used across its assay portfolio.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 1,100 InGenius and BeGenius instruments installed globally
+2 more records
Product overview1 text field

ELITechGroup is an integrated in-vitro diagnostics company organized into three specialized business units: Molecular Diagnostics (MDx), Biomedical Systems (EBS), and Microbiology (EM). The Molecular Diagnostics division centers on three sample-to-result PCR platforms: ELITe InGenius (launched 2016), ELITe BeGenius (launched 2021), and the recently launched MyGenius PRO (2026, developed with Hitachi High-Tech). The portfolio includes nearly 60 CE-IVD/IVDR assays using proprietary MGB (Minor Groove Binder) probe technology, including gastrointestinal panels (Bacterial, Parasitic, Viral, Norovirus kits), infectious disease tests (HIV, HCV, HBV, CMV, EBV, BK virus), and respiratory panels. The Biomedical Systems unit offers slide stainers (Aerospray), osmometers (Osmomat), cytocentrifuges (CytoPro), ESR analyzers, digital cell analyzers, and the ChloroChek Chloridometer. The Microbiology unit provides products for urogenital mycoplasma, pathogenic yeast, UTI, and veterinary diagnostics.

Product and service16 records
1ELITe InGenius
CategoryMolecular diagnostics instrument
Description

Fully automated sample-to-result molecular diagnostics PCR instrument for clinical and diagnostic laboratories, supporting infectious disease, transplant, and gastrointestinal testing.

2ELITe BeGenius
CategoryMolecular diagnostics instrument
Description

Higher-throughput fully automated sample-to-result PCR platform using the same reagent menu as InGenius, targeted at higher-volume clinical diagnostic laboratories.

3MyGenius PRO
CategoryMolecular diagnostics instrument
Description

High-throughput fully automated sample-to-answer molecular diagnostics system for infectious disease testing based on PCR technology, developed with Hitachi High-Tech Corporation and featuring continuous sample/reagent loading and random-access capabilities.

4GI Bacterial PLUS ELITe MGB Kit
CategoryDiagnostic reagent kit
Description

CE-IVDR certified PCR assay kit for diagnosing gastrointestinal bacterial infections, run on ELITe InGenius and BeGenius systems and targeted at hospital and reference laboratories.

5GI Parasitic PLUS ELITe MGB Kit
CategoryDiagnostic reagent kit
Description

IVDR-certified PCR assay kit for gastrointestinal parasitic infections, used on ELITe InGenius and BeGenius platforms in clinical laboratories.

6GI Viral PLUS ELITe MGB Kit
CategoryDiagnostic reagent kit
Description

PCR assay kit for gastrointestinal viral infections run on ELITe InGenius and BeGenius systems in clinical laboratories.

7GI Norovirus PLUS ELITe MGB Kit
CategoryDiagnostic reagent kit
Description

PCR assay kit for norovirus gastrointestinal infections used on ELITe InGenius and BeGenius systems.

8Aerospray Slide Stainers / Cytocentrifuges
CategoryBiomedical laboratory instrument
Description

Automated slide staining and cytocentrifugation instruments for clinical laboratories performing microscopy-based diagnostics.

9ChloroChek Chloridometer
CategoryBiomedical laboratory instrument
Description

Chloridometer instrument for measuring chloride concentration in biological samples such as sweat for cystic fibrosis testing in clinical laboratories.

10CytoPro Cytocentrifugation
CategoryBiomedical laboratory instrument
Description

Cytocentrifuge system for cell preparation and concentration in clinical cytology diagnostics.

11Digital Cell Analyzers
CategoryBiomedical laboratory instrument
Description

Digital cell analysis instruments for automated cell counting and analysis in clinical laboratories.

12Erythrocyte Sedimentation Rate Analyzers
CategoryBiomedical laboratory instrument
Description

Automated ESR analyzers for measuring red blood cell sedimentation rate in blood samples.

13Macroduct Advanced
CategoryBiomedical laboratory instrument
Description

Advanced macroduct sweat collection system for clinical diagnostics including cystic fibrosis testing.

14Osmometers (Osmomat)
CategoryBiomedical laboratory instrument
Description

Osmometry instruments for measuring osmolality of biological samples in clinical laboratories.

15Microbiology Diagnostic Kits (Human and Veterinary)
CategoryMicrobiology diagnostics
Description

Microbiology diagnostic products for urogenital mycoplasma, pathogenic yeast, urinary tract infection, and veterinary applications, sold to clinical and veterinary laboratories.

16LABOSPECT GA-5
CategoryMolecular diagnostics instrument
Description

Regional Japan-market variant of the MyGenius PRO automated PCR platform, distributed by Hitachi High-Tech under its own brand in compliance with Japanese diagnostic regulations.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-01
Description

Collaboration, Manufacturing and Supply Agreement for molecular testing for infectious disease. Hitachi High-Tech supplies a jointly developed fully automated PCR testing system to Elitech, featuring continuous sample and reagent loading, random-access capabilities, and fully automated functions from sample preparation to measurement. Joint development focuses on creating an innovative and flexible PCR platform to enhance operational efficiency in microbiology and virology laboratories. Hitachi High-Tech separately markets the platform as LABOSPECT GA-5 in Japan.

Strategic tierCoreTypeOthersAnnounced on2024-05-01
Description

Elitech Group is now a Bruker company following acquisition in May 2024 for approximately $930.9 million. Elitech operates as part of Bruker's Microbiology & Infection Diagnostics (BMID) division, maintaining its product portfolio and market presence while benefiting from Bruker's science and technology leadership.

Strategic tierMinorTypeOthersAnnounced on2024-01-01
Description

ElitechGroup supports the AIRC Foundation by funding a two-year postdoctoral fellowship to a young researcher.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-07-22
Description

Strategic partnership for monkeypox virus testing across Europe. BioPerfectus provides its Monkeypox Virus Real Time PCR Kit (CE marked) which is exclusively offered for ELITe InGenius and BeGenius instruments to provide the first fully automated monkeypox diagnostic solution on the market. The combination supports major reference laboratories, hospitals, and disease control centers in Europe.

5AIDES
Strategic tierMinorTypeOthersAnnounced on2022-04-28
Description

Charitable contribution to French association fighting HIV/AIDS. Elitech Group allocated donations to support the organization's mission in addressing public health problems related to HIV.

elitechgroup.com
Strategic tierMinorTypeOthersAnnounced on2022-04-28
Description

Charitable contribution to French cancer research association. Elitech Group supported the organization's actions in advancing the fight against cancer.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DiaSorin's LIAISON MDX and Simplexa molecular platforms are directly comparable to Elitech's sample-to-result systems, particularly in transplant and infectious disease testing.

TypeDirect peer
Description

bioMérieux's BioFire FilmArray and EM (microbiology) business is a direct peer to Elitech's Molecular Diagnostics and Microbiology units in clinical infectious disease diagnostics.

TypeDirect peer
Description

Cepheid's GeneXpert is the leading fully automated sample-to-result PCR platform in infectious disease diagnostics, directly competing with Elitech's InGenius/BeGenius/MyGenius PRO in hospital and reference-lab settings.

TypeDirect peer
Description

Qiagen's QIAstat-Dx and sample-preparation/PCR reagent portfolio competes directly with Elitech's sample-to-result PCR platforms and MGB-based assay menu in clinical and research laboratories.

TypeBroad incumbent
Description

Roche's cobas 6800/8800 and cobas Liat systems are broad incumbents in automated molecular diagnostics and IVD, with significantly larger menus and global reach than Elitech.

TypeDirect peer
Description

QuidelOrtho's Savanna and Sofia molecular/rapid diagnostics platforms target similar point-of-care and laboratory customers, competing with Elitech on infectious disease workflow efficiency.

TypeDirect peer
Description

Seegene's Allplex and automated PCR assay portfolio competes with Elitech's MGB-based kits in syndromic and infectious disease molecular testing for clinical laboratories.

TypeBroad incumbent
Description

Abbott's m2000 and Alinity m systems are broad molecular diagnostics incumbents offering automated PCR testing across infectious disease, transplant, and oncology — competing with Elitech in similar hospital settings.

TypeDirect peer
Description

Hologic's Panther / Panther Fusion systems provide fully automated molecular sample-to-result testing for women's health, infectious disease, and virology — directly overlapping with Elitech's transplant and infectious disease menu.

TypeDirect peer
Description

BD's MAX System and BD COR are fully automated sample-to-result molecular platforms targeting similar hospital and laboratory customers as Elitech's InGenius and BeGenius systems.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Elitech Group

In-vitro Diagnosticselitechgroup.com

Elitech Group firmographics

Firmographics
Name
Elitech Group
Legal name
ELITechGroup SAS
Website
https://elitechgroup.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

Elitech Group industry classification

Industry
Product category
In-vitro Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro primary industry
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
akta.pro secondary industries
IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

Keywords

  • In vitro diagnostics
  • Molecular diagnostics instruments
  • PCR testing systems
  • Clinical laboratory reagents
  • Biomedical analyzers

Where Elitech Group is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices9 records

Markets served

Elitech Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. In-vitro Diagnostic Products: Development, manufacturing, and marketing of diagnostic products including instruments (InGenius, BeGenius sample-to-result systems), reagents (PCR assay kits), and software for molecular diagnostics, biomedical systems, and microbiology applications.
  2. Diagnostic Reagents and Kits: CE-IVDR certified PCR assay kits including GI Bacterial PLUS ELITe MGB Kit, gastrointestinal panels, infectious disease assays for CMV, EBV, BK virus, HIV, HBV, HCV, and HHV-6, with nearly 60 CE-IVD parameters available.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Elitech Group product offering

Product offering

Core offering

Elitech Group develops, manufactures, and markets in-vitro diagnostic (IVD) products organized into three business areas: Molecular Diagnostics (PCR-based sample-to-result systems such as InGenius and BeGenius plus CE-IVD/IVDR assay kits), Biomedical Systems (automated slide stainers, osmometers, cytocentrifuges, ESR analyzers, chloridometers, digital cell analyzers), and Microbiology (human and veterinary diagnostic kits and sampling/transport products). It also sells proprietary MGB (Minor Groove Binder) probe chemistry and reagents used across its assay portfolio.

Product overview

ELITechGroup is an integrated in-vitro diagnostics company organized into three specialized business units: Molecular Diagnostics (MDx), Biomedical Systems (EBS), and Microbiology (EM). The Molecular Diagnostics division centers on three sample-to-result PCR platforms: ELITe InGenius (launched 2016), ELITe BeGenius (launched 2021), and the recently launched MyGenius PRO (2026, developed with Hitachi High-Tech). The portfolio includes nearly 60 CE-IVD/IVDR assays using proprietary MGB (Minor Groove Binder) probe technology, including gastrointestinal panels (Bacterial, Parasitic, Viral, Norovirus kits), infectious disease tests (HIV, HCV, HBV, CMV, EBV, BK virus), and respiratory panels. The Biomedical Systems unit offers slide stainers (Aerospray), osmometers (Osmomat), cytocentrifuges (CytoPro), ESR analyzers, digital cell analyzers, and the ChloroChek Chloridometer. The Microbiology unit provides products for urogenital mycoplasma, pathogenic yeast, UTI, and veterinary diagnostics.

Differentiator

Problem solved

Functional benefit

Products and services

  • ELITe InGenius Fully automated sample-to-result molecular diagnostics PCR instrument for clinical and diagnostic laboratories, supporting infectious disease, transplant, and gastrointestinal testing.
  • ELITe BeGenius Higher-throughput fully automated sample-to-result PCR platform using the same reagent menu as InGenius, targeted at higher-volume clinical diagnostic laboratories.
  • MyGenius PRO High-throughput fully automated sample-to-answer molecular diagnostics system for infectious disease testing based on PCR technology, developed with Hitachi High-Tech Corporation and featuring continuous sample/reagent loading and random-access capabilities.
  • GI Bacterial PLUS ELITe MGB Kit CE-IVDR certified PCR assay kit for diagnosing gastrointestinal bacterial infections, run on ELITe InGenius and BeGenius systems and targeted at hospital and reference laboratories.
  • GI Parasitic PLUS ELITe MGB Kit IVDR-certified PCR assay kit for gastrointestinal parasitic infections, used on ELITe InGenius and BeGenius platforms in clinical laboratories.
  • GI Viral PLUS ELITe MGB Kit PCR assay kit for gastrointestinal viral infections run on ELITe InGenius and BeGenius systems in clinical laboratories.
  • GI Norovirus PLUS ELITe MGB Kit PCR assay kit for norovirus gastrointestinal infections used on ELITe InGenius and BeGenius systems.
  • Aerospray Slide Stainers / Cytocentrifuges Automated slide staining and cytocentrifugation instruments for clinical laboratories performing microscopy-based diagnostics.
  • ChloroChek Chloridometer Chloridometer instrument for measuring chloride concentration in biological samples such as sweat for cystic fibrosis testing in clinical laboratories.
  • CytoPro Cytocentrifugation Cytocentrifuge system for cell preparation and concentration in clinical cytology diagnostics.
  • Digital Cell Analyzers Digital cell analysis instruments for automated cell counting and analysis in clinical laboratories.
  • Erythrocyte Sedimentation Rate Analyzers Automated ESR analyzers for measuring red blood cell sedimentation rate in blood samples.
  • Macroduct Advanced Advanced macroduct sweat collection system for clinical diagnostics including cystic fibrosis testing.
  • Osmometers (Osmomat) Osmometry instruments for measuring osmolality of biological samples in clinical laboratories.
  • Microbiology Diagnostic Kits (Human and Veterinary) Microbiology diagnostic products for urogenital mycoplasma, pathogenic yeast, urinary tract infection, and veterinary applications, sold to clinical and veterinary laboratories.
  • LABOSPECT GA-5 Regional Japan-market variant of the MyGenius PRO automated PCR platform, distributed by Hitachi High-Tech under its own brand in compliance with Japanese diagnostic regulations.

Quantifiable outcome

  • Over 1,100 InGenius and BeGenius instruments installed globally
  • +2 more outcomes

Companies that use Elitech Group

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Elitech Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Elitech Group partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Hitachi High-Tech CorporationcoreStrategic or Co-development Partner · 1 December 2025Collaboration, Manufacturing and Supply Agreement for molecular testing for infectious disease. Hitachi High-Tech supplies a jointly developed fully automated PCR testing system to Elitech, featuring continuous sample and reagent loading, random-access capabilities, and fully automated functions from sample preparation to measurement. Joint development focuses on creating an innovative and flexible PCR platform to enhance operational efficiency in microbiology and virology laboratories. Hitachi High-Tech separately markets the platform as LABOSPECT GA-5 in Japan.
  • Bruker CorporationcoreOthers · 1 May 2024Elitech Group is now a Bruker company following acquisition in May 2024 for approximately $930.9 million. Elitech operates as part of Bruker's Microbiology & Infection Diagnostics (BMID) division, maintaining its product portfolio and market presence while benefiting from Bruker's science and technology leadership.
  • AIRC FoundationminorOthers · 1 January 2024ElitechGroup supports the AIRC Foundation by funding a two-year postdoctoral fellowship to a young researcher.
  • BioPerfectus (Jiangsu Bioperfectus Technologies Co., Ltd.)coreStrategic or Co-development Partner · 22 July 2022Strategic partnership for monkeypox virus testing across Europe. BioPerfectus provides its Monkeypox Virus Real Time PCR Kit (CE marked) which is exclusively offered for ELITe InGenius and BeGenius instruments to provide the first fully automated monkeypox diagnostic solution on the market. The combination supports major reference laboratories, hospitals, and disease control centers in Europe.
  • AIDESminorOthers · 28 April 2022Charitable contribution to French association fighting HIV/AIDS. Elitech Group allocated donations to support the organization's mission in addressing public health problems related to HIV.
  • La Ligue contre le cancerminorOthers · 28 April 2022Charitable contribution to French cancer research association. Elitech Group supported the organization's actions in advancing the fight against cancer.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Elitech Group competitors and assessment

Company assessment

Direct peers

  • DiaSorin: DiaSorin's LIAISON MDX and Simplexa molecular platforms are directly comparable to Elitech's sample-to-result systems, particularly in transplant and infectious disease testing.
  • bioMérieux: bioMérieux's BioFire FilmArray and EM (microbiology) business is a direct peer to Elitech's Molecular Diagnostics and Microbiology units in clinical infectious disease diagnostics.
  • Cepheid (Danaher): Cepheid's GeneXpert is the leading fully automated sample-to-result PCR platform in infectious disease diagnostics, directly competing with Elitech's InGenius/BeGenius/MyGenius PRO in hospital and reference-lab settings.
  • Qiagen: Qiagen's QIAstat-Dx and sample-preparation/PCR reagent portfolio competes directly with Elitech's sample-to-result PCR platforms and MGB-based assay menu in clinical and research laboratories.
  • QuidelOrtho: QuidelOrtho's Savanna and Sofia molecular/rapid diagnostics platforms target similar point-of-care and laboratory customers, competing with Elitech on infectious disease workflow efficiency.
  • Seegene: Seegene's Allplex and automated PCR assay portfolio competes with Elitech's MGB-based kits in syndromic and infectious disease molecular testing for clinical laboratories.
  • Hologic: Hologic's Panther / Panther Fusion systems provide fully automated molecular sample-to-result testing for women's health, infectious disease, and virology — directly overlapping with Elitech's transplant and infectious disease menu.
  • Becton Dickinson (BD): BD's MAX System and BD COR are fully automated sample-to-result molecular platforms targeting similar hospital and laboratory customers as Elitech's InGenius and BeGenius systems.

Broad incumbents

  • Roche Diagnostics: Roche's cobas 6800/8800 and cobas Liat systems are broad incumbents in automated molecular diagnostics and IVD, with significantly larger menus and global reach than Elitech.
  • Abbott: Abbott's m2000 and Alinity m systems are broad molecular diagnostics incumbents offering automated PCR testing across infectious disease, transplant, and oncology — competing with Elitech in similar hospital settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Elitech Group social profiles

Digital presence

Elitech Group compliance and trust

Trust signal

Compliance4 records

Elitech Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Elitech Group leadership team

Management profile

Number of profiles

Profiles7 records

Elitech Group subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Elitech Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Elitech Group M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elitech Group

What does Elitech Group do?

Elitech Group develops, manufactures, and markets in-vitro diagnostic (IVD) products organized into three business areas: Molecular Diagnostics (PCR-based sample-to-result systems such as InGenius and BeGenius plus CE-IVD/IVDR assay kits), Biomedical Systems (automated slide stainers, osmometers, cytocentrifuges, ESR analyzers, chloridometers, digital cell analyzers), and Microbiology (human and veterinary diagnostic kits and sampling/transport products). It also sells proprietary MGB (Minor Groove Binder) probe chemistry and reagents used across its assay portfolio.

Is Elitech Group a public or private company?

Elitech Group is a private company. It is classified as corporate owned and is currently operating.

When was Elitech Group founded?

Elitech Group was founded in 1992. It employs 251 to 500 people.

Where is Elitech Group based?

Elitech Group is headquartered in Paris, France, in the Europe region.

How does Elitech Group make money?

Two revenue lines are on record. In-vitro Diagnostic Products are the primary driver. The others are diagnostic Reagents and Kits.

Who are Elitech Group's main competitors?

Direct peers on record are DiaSorin, bioMérieux, Cepheid (Danaher), Qiagen, QuidelOrtho, Seegene, Hologic and Becton Dickinson (BD). Broad incumbents are Roche Diagnostics and Abbott.

Does Elitech Group have an API?

No public API is recorded for Elitech Group.

What industry is Elitech Group in?

Elitech Group's product category is In-vitro Diagnostics. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Lab ManagerBruker Surpasses Q1 2026 Expectations Amid Strategic Shift to Post-Genomic ResearchBruker Corporation reported Q1 2026 total revenue of $823.4 million, beating analyst expectations with a non-GAAP EPS of $0.31 despite a 4.4% decline in organic revenue. The company is driving growth through strategic acquisitions like NanoString and ELITechGroup, while expanding its AI-driven laboratory software and spatial biology portfolios to offset volatile U.S. academic demand.Medical Device NetworkBruker unveils MyGenius PRO diagnostics systemBruker launched its MyGenius PRO automated molecular diagnostics system at ESCMID 2026, targeting infectious disease testing. The IVDR menu includes CMV, EBV, and BKV assays for immunocompromised patients, with planned expansions for HIV, HBV, HCV, and HHV-6. The system is already installed at a European transplant centre.openPR.comLeading Firms Propelling Innovation and Growth in the Blood Culture Tests MarketThe Business Research Company published a market report projecting the blood culture tests market to reach $14.77 billion by 2030, growing at a compound annual growth rate of 14.5%, driven by demand for faster diagnostics, AI-assisted laboratory operations, and automated blood culture systems. In February 2024, Bruker Corporation completed the acquisition of Italy-based ELITechGroup for $1,008.9 million to strengthen its molecular diagnostic assays for blood-borne pathogens and expand its automated microbiology portfolio. In April 2024, Mindray Medical International Limited launched mid-volume laboratory solutions designed to support mid-tier laboratories with improved diagnostic capabilities.openPR.comMeningitis Diagnostic Testing Market 2025 | Industry Developments, Future Growth, Share & Industry Insights | Seegene Inc., BioFire Diagnostics LLC (BioMérieux), Teco Diagnostics, ELITech Group, TranDataM Intelligence forecasts the meningitis diagnostic testing market to grow at a 3.3% CAGR from 2024 to 2031, with North America holding about 38.4% of the market share. Recent M&A activity includes QuidelOrtho's intent to acquire LEX Diagnostics and Waters' $17.5B merger with Becton Dickinson's diagnostics business.PR NewswireMolecular Diagnostics Market to Hit USD 33.7 Billion by 2032, Growing at 7.3% CAGR | SkyQuest Technology ConsultingThe global molecular diagnostics market is valued at USD 19.1 billion in 2024 and is projected to reach USD 33.7 billion by 2032, growing at a 7.3% CAGR, driven by advances in genomic technologies, rising demand for early disease detection, and adoption of personalized medicine. In July 2024, Illumina completed the acquisition of Fluent BioSciences to strengthen its portfolio in high-resolution genomic tools for oncology and immunology applications. In May 2024, Bruker Corporation completed the €870 million acquisition of ELITechGroup, positioning itself as an innovative infectious disease company in the IVD industry.BrukerBruker Completes Acquisition of Molecular Diagnostics Innovator ELITechBruker Corporation closed its acquisition of ELITechGroup for €870 million in cash, excluding the carved-out clinical chemistry business, with ELITech reporting FY 2023 revenue of about €150 million and over 80% consumables revenue. Bruker expects the ELITech business to generate roughly $100 million in revenue in 2024, non-GAAP EBIT margins above 20%, and FY 2024 EPS accretion of $0.08-$0.10.ElitechgroupELITechGroup launches CE-IVDR certified GI Bacterial PLUS ELITe MGB® Kit and expands in vitro diagnostic portfolioELITechGroup announced the launch of its GI Bacterial PLUS ELITe MGB® Kit, a CE-IVDR certified in vitro assay targeting Campylobacter, Clostridium difficile, Salmonella, Shigella and Yersinia enterocolitica in stool specimens. The kit is validated with ELITe InGenius and ELITe BeGenius instruments. Three additional gastrointestinal kits covering parasitic, viral and norovirus pathogens are planned for launch within the next quarter.ElitechgroupELITechGroup unveils plans for its next innovation: the launch of a high throughput sample-to-result instrument for molecular diagnosticsAt the ECCMID congress in Copenhagen on 15 April 2023, ELITech Group announced a new high throughput sample-to-result instrument for molecular diagnostics, to be launched in Europe by the end of 2024. The system will use the same reagents as its InGenius and BeGenius platforms, which together have over 1,100 instruments installed and more than 50 CE-IVD parameters.PR NewswireInsights on the Blood Temperature Indicator Global Market to 2028 - Featuring Elitech, Thermo Fisher Scientific, Sercalia and Zebra Technologies Among OthersResearchAndMarkets has published a forecast report projecting the global blood temperature indicator market to grow from US$ 216.05 million in 2021 to US$ 504.37 million by 2028, representing a CAGR of 12.9%. This growth is primarily driven by increasing demand for blood transfusions and donations due to chronic diseases and trauma cases, alongside the critical need for safe transportation of blood components. Key industry players profiled in the analysis include Elitech, Thermo Fisher Scientific, Sercalia, Zebra Technologies, and 3M.PR NewswireVacuum Blood Collection Tube Market to Record 7.02 % Y-O-Y Growth Rate in 2022 | Evolving Opportunities with Becton Dickinson and Co., CML Biotech Pvt. Ltd. & ELITech Group | 17000+ Technavio ReportsTechnavio has released a market research report projecting the vacuum blood collection tube market to grow by USD 906.90 million from 2021 to 2026, at a CAGR of 7.33%, with 7.02% year-over-year growth expected in 2022. North America is forecast to contribute 36% of market growth, driven by high blood transfusion rates. Key growth drivers include increasing prevalence of chronic conditions and rising clinical trials, while a shortage of trained professionals is identified as a potential restraint.